Cargando…
Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study
Background: The incidence of depressive symptoms (DS) in patients with stable coronary artery disease (SCAD) is significantly higher than those in healthy population, and that DS are independent risk factors for cardiovascular events. Previous studies have reported that fibroblast growth factor 21 (...
Autores principales: | Wu, Yeshun, Chen, Zijun, Duan, Jiahao, Huang, Kai, Zhu, Bin, Yang, Ling, Zheng, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873935/ https://www.ncbi.nlm.nih.gov/pubmed/33584362 http://dx.doi.org/10.3389/fpsyt.2020.587492 |
Ejemplares similares
-
Prevalence and predisposing factors of depressive symptoms in patients with stable coronary artery disease: a cross-sectional single-center study
por: Wu, Yeshun, et al.
Publicado: (2019) -
FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012) -
Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
por: Gao, Xiang, et al.
Publicado: (2021) -
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023) -
Comment on: “Fibroblast growth factor 21 controls mitophagy and muscle mass” by Oost et al.
por: Wu, Yeshun, et al.
Publicado: (2019)